Market Size of Bioactive Wound Dressing Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 11.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Bioactive Wound Dressing Market Analysis
The bioactive wound dressing market is expected to register a CAGR of 11% during the forecast period.
The COVID-19 outbreak impacted the bioactive wound dressing market and the overall healthcare sector, as hospitals and healthcare services were reduced due to social distancing measures taken by governments worldwide. The COVID-19 pandemic affected the global economy and greatly impacted the functioning of general hospital care for non-COVID-19 patients in hospitals globally. The article presented by UpToDate Inc., updated in June 2022, indicated that the delivery of wound care, which should be regarded as an essential medical service, shifted during the COVID-19 pandemic. During the pandemic, significant importance was placed on wound care to prevent serious wound complications by minimizing hospitalization and surgery rather than completing wound healing. The reduction in the available bioactive wound dressing services was adversely impacted by the COVID-19 pandemic but has recovered in the two years to post strong growth.
The bioactive wound dressing market is driven by advancements in technology, the growing aging population, the rising burden of chronic wounds, and problems associated with conventional wound healing procedures. An article published in the Journal of Advances in Wound Care in March 2021 indicated that chronic wounds impact the quality of life (QoL) of nearly 2.5% of the US population and that wound care management has an important economic impact on the US healthcare sector. Chronic wounds are most commonly seen in the elderly population of the nation. With the growing geriatric population in the United States, the incidence of chronic wounds is expected to increase, thereby aiding the growth of the market studied. According to the World Bank Report 2022, there were 11,075 surgical procedures (per 100,000 population) in the European Union. The rising number of surgeries in Europe has been directly contributing to the growth of the market studied in the long run, as wounds have also been increasing due to surgeries. Therefore, with the rising volume of surgical procedures, the market studied is expected to grow over the forecast period.
However, the high cost of treatment and unfavorable reimbursement policies are a few factors hindering the growth of the bioactive wound dressing market.
Bioactive Wound Dressing Industry Segmentation
As per the scope, bioactive dressings are those that either supply bioactive molecules directly to the wound or are made from materials with endogenous activity. These substances include bio textiles, alginates, collagens, chitosan, chitin, and derivatives of those substances. In bioactive wound care, the dressing is different from the normal bandage and is designed specially to stay in direct contact with the wound.
The bioactive wound dressing market is segmented by product (hydrocolloids, alginate dressing, skin substitutes, antimicrobial dressing, and other products), application (wounds, burns, ulcers, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.
| By Product | |
| Hydrocolloids | |
| Alginate Dressing | |
| Skin Substitutes | |
| Antimicrobial Dressing | |
| Other Products |
| By Application | |
| Wounds | |
| Burns | |
| Ulcers | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bioactive Wound Dressing Market Size Summary
The bioactive wound dressing market is poised for substantial growth, driven by technological advancements and an increasing aging population. The market's expansion is further supported by the rising incidence of chronic wounds, particularly among the elderly, and the challenges associated with traditional wound healing methods. The COVID-19 pandemic initially disrupted the market by reducing healthcare services, but it has since rebounded, showing strong growth. The market is also benefiting from the increasing number of surgical procedures, especially in Europe, which contributes to the rising demand for effective wound care solutions. However, the market faces challenges such as high treatment costs and unfavorable reimbursement policies, which could impede its growth trajectory.
North America is expected to hold a significant share of the global bioactive wound dressing market, driven by a rapidly growing aging population and a high prevalence of diabetes. The developed healthcare system in the region, which is quick to adopt novel innovations, further supports market growth. The increasing number of diabetic cases is likely to lead to a rise in diabetic ulcer cases, propelling market demand. The market is moderately fragmented, with key players like 3M, Convatec Group PLC, and Smith & Nephew PLC actively engaging in collaborations, mergers, and acquisitions to strengthen their market presence. Recent product launches, such as Medline's Optifoam Gentle EX Foam dressing, highlight the ongoing innovation and competitive dynamics within the industry.
Bioactive Wound Dressing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Chronic Wounds and Associated Diseases
-
1.2.2 Advancements in Bioactive Wound Dressings
-
-
1.3 Market Restraints
-
1.3.1 Lack of Proper Reimbursement
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Hydrocolloids
-
2.1.2 Alginate Dressing
-
2.1.3 Skin Substitutes
-
2.1.4 Antimicrobial Dressing
-
2.1.5 Other Products
-
-
2.2 By Application
-
2.2.1 Wounds
-
2.2.2 Burns
-
2.2.3 Ulcers
-
2.2.4 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Bioactive Wound Dressing Market Size FAQs
What is the current Bioactive Wound Dressing Market size?
The Bioactive Wound Dressing Market is projected to register a CAGR of 11% during the forecast period (2024-2029)
Who are the key players in Bioactive Wound Dressing Market?
3M, B. Braun SE, Convatec Group PLC, Monlnlycke Health Care AB and Smith & Nephew PLC are the major companies operating in the Bioactive Wound Dressing Market.
